Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach

NCT05894915 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2023
Completion date
December 31, 2025
Enrollment
390 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma, tumor molecular features screening model